Colombian Biological Derivatives Group SAS

Colombian Biological Derivatives Group SAS is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about Colombian Biological Derivatives Group SAS. CBD GROUP SAS has a business model based on associativity and the cooperation of producers in the national and international industry of medicinal cannabis products and active ingredients and their derivatives, thus generating a firm socio-cultural impact in the communities and territories affected by the armed conflict in Colombia. CBD Group SAS aim is to supply the demand within the standards and parameters established in the medicinal cannabis industry, which facilitates the relationship and bond of small and medium-sized companies active in the market.